Eupraxia Pharmaceuticals Statistics

Total Valuation

TSX:EPRX has a market cap or net worth of CAD 265.02 million. The enterprise value is 279.20 million.

Market Cap	265.02M
Enterprise Value	279.20M

Important Dates

The last earnings date was Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:EPRX has 35.96 million shares outstanding. The number of shares has increased by 21.81% in one year.

Current Share Class	35.96M
Shares Outstanding	35.96M
Shares Change (YoY)	+21.81%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	22.76%
Owned by Institutions (%)	5.65%
Float	24.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	9.26
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.62

Financial Position

The company has a current ratio of 8.72, with a Debt / Equity ratio of 0.00.

Current Ratio	8.72
Quick Ratio	7.60
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-81.82

Financial Efficiency

Return on equity (ROE) is -169.25% and return on invested capital (ROIC) is -93.38%.

Return on Equity (ROE)	-169.25%
Return on Assets (ROA)	-75.00%
Return on Invested Capital (ROIC)	-93.38%
Return on Capital Employed (ROCE)	-138.93%
Revenue Per Employee	n/a
Profits Per Employee	-1.21M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TSX:EPRX has paid 13,883 in taxes.

Income Tax	13,883
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +108.78% in the last 52 weeks. The beta is 1.54, so TSX:EPRX's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	+108.78%
50-Day Moving Average	6.88
200-Day Moving Average	5.35
Relative Strength Index (RSI)	52.59
Average Volume (20 Days)	24,803

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-39.75M
Pretax Income	-39.59M
Net Income	-40.07M
EBITDA	-39.57M
EBIT	-39.75M
Earnings Per Share (EPS)	-1.12

Full Income Statement

Balance Sheet

The company has 26.96 million in cash and 47,824 in debt, giving a net cash position of 26.91 million or 0.75 per share.

Cash & Cash Equivalents	26.96M
Total Debt	47,824
Net Cash	26.91M
Net Cash Per Share	0.75
Equity (Book Value)	28.61M
Book Value Per Share	-0.35
Working Capital	27.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -41.57 million and capital expenditures -575,357, giving a free cash flow of -42.15 million.

Operating Cash Flow	-41.57M
Capital Expenditures	-575,357
Free Cash Flow	-42.15M
FCF Per Share	-1.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:EPRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.81%
Shareholder Yield	n/a
Earnings Yield	-15.12%
FCF Yield	-15.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1